Technology ❯ Biotechnology

Gene Editing Technologies

CRISPR Programmable Recombinases CRISPR Improvements CRISPR-Cas9 RNA Editing Platforms Therapeutic Applications CRISPR and Related Technologies CRISPR-Cas Prime Editing Photoactivatable Systems Base Editing

Lilly Signs Up to $1.12 Billion Gene-Editing Pact to Tackle Hearing Loss

The agreement showcases Lilly's bid to broaden growth beyond incretin medicines.

Lilly Strikes Up to $1.12 Billion Pact With Seamless Therapeutics for Hearing‑Loss Gene Editing

Precision Base Editor Restores Mitochondrial DNA in Patient Cells

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion